Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Diabetologia Année : 2020

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

1 CHU Nantes - Centre Hospitalier Universitaire de Nantes = Nantes University Hospital
2 ITX - ITX - unité de recherche de l'institut du thorax
3 CHU Amiens-Picardie
4 PERITOX - Périnatalité et Risques Toxiques - UMR INERIS_I 1 UPJV
5 CHU Angers - Centre Hospitalier Universitaire d'Angers
6 Centre Hospitalier Sud Francilien
7 CHBA - Centre hospitalier Bretagne Atlantique (Morbihan)
8 CHRU Lille - Centre Hospitalier Régional Universitaire [CHU Lille]
9 HIA Begin - Hôpital d'Instruction des Armées Begin [Saint-Mandé, France]
10 Service de Diabétologie - Endocrinologie [CHRU Besançon]
11 AP-HP - Hôpital Antoine Béclère [Clamart]
12 CHU Pitié-Salpêtrière [AP-HP]
13 Service des maladies infectieuses et tropicales [CHU Nantes]
14 PHAR [Poitiers] - Pharmacologie des anti-infectieux
15 Fédération française des diabétiques
16 USPC - Université Sorbonne Paris Cité
17 CIC Nantes - Centre d’Investigation Clinique de Nantes
18 C2VN - Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research
19 CarMeN - Cardiovasculaire, métabolisme, diabétologie et nutrition
20 CHD Vendée - Centre Hospitalier Départemental - Hôpital de La Roche-sur-Yon
21 Service d'endocrinologie, nutrition et maladies métaboliques [Hôpital Nord - APHM]
22 CHRU Brest - Centre Hospitalier Régional Universitaire de Brest
23 Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Ponchaillou]
24 CIC - Centre d'Investigation Clinique [Rennes]
25 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]
26 HUS - Les Hôpitaux Universitaires de Strasbourg
27 Service d'endocrinologie, diabétologie, nutrition
28 DC2N - Différenciation et communication neuronale et neuroendocrine
29 Service d'endocrinologie, diabétologie et maladies métaboliques [Rouen]
30 CRC (UMR_S_1138 / U1138) - Centre de Recherche des Cordeliers
31 Service des urgences [CHU Poitiers] = Emergency Department (ER) [Poitiers University Hospital]
32 CIC 1402 - CIC Poitiers – Centre d'investigation clinique de Poitiers
33 PhyMedExp - Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046]
34 I2MC - Institut des Maladies Métaboliques et Cardiovasculaires
35 CHU Saint-Antoine [AP-HP]
Coralie Amadou
Emmanuel Cosson
  • Fonction : Auteur
  • PersonId : 1136642

Résumé

Aims/hypothesis Coronavirus disease-2019 (COVID-19) is a life-threatening infection caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus. Diabetes has rapidly emerged as a major comorbidity for COVID-19 severity. However, the phenotypic characteristics of diabetes in COVID-19 patients are unknown.Methods We conducted a nationwide multicentre observational study in people with diabetes hospitalised for COVID-19 in 53 French centres in the period 10-31 March 2020. The primary outcome combined tracheal intubation for mechanical ventilation and/or death within 7 days of admission. Age-and sex-adjusted multivariable logistic regressions were performed to assess the prognostic value of clinical and biological features with the endpoint. ORs are reported for a 1 SD increase after standardisation.Results The current analysis focused on 1317 participants: 64.9% men, mean age 69.8 ± 13.0 years, median BMI 28.4 (25th-75th percentile: 25.0-32.7) kg/m 2 ; with a predominance of type 2 diabetes (88.5%). Microvascular and macrovascular diabetic complications were found in 46.8% and 40.8% of cases, respectively. The primary outcome was encountered in 29.0% (95% CI 26.6, 31.5) of participants, while 10.6% (9.0, 12.4) died and 18.0% (16.0, 20.2) were discharged on day 7. In univariate analysis, characteristics prior to admission significantly associated with the primary outcome were sex, BMI and previous treatment with renin-angiotensin-aldosterone system (RAAS) blockers, but not age, type of diabetes, HbA 1c diabetic complications or glucose-lowering therapies. In multivariable analyses with covariates prior to admission, only BMI remained positively associated with the primary outcome (OR 1.28 [1.10, 1.47]). On admission, dyspnoea (OR 2.10 [1.31, 3.35]), as well as lymphocyte count (OR 0.67 [0.50, 0.88]), C-reactive protein (OR 1.93 [1.43, 2.59]) and AST (OR 2.23 [1.70, 2.93]) levels were independent predictors of the primary outcome. Finally, age (OR 2.48 [1.74, 3.53]), treated obstructive sleep apnoea (OR 2.80 [1.46, 5.38]), and microvascular (OR 2.14 [1.16, 3.94]) and macrovascular complications (OR 2.54 [1.44, 4.50]) were independently associated with the risk of death on day 7.Conclusions/interpretations: In people with diabetes hospitalised for COVID-19, BMI, but not long-term glucose control, was positively and independently associated with tracheal intubation and/or death within 7 days
Fichier principal
Vignette du fichier
Cariou-2020-Phenotypic characteristics and prognosis of inpatients.pdf (1.15 Mo) Télécharger le fichier
2020 Cariou et al., correction to.pdf (163.38 Ko) Télécharger le fichier
Origine Publication financée par une institution
Commentaire eratum Diabetologia (2020) 63:1953–1957
Loading...

Dates et versions

hal-02667655 , version 1 (01-06-2020)
hal-02667655 , version 2 (02-09-2020)

Licence

Identifiants

Citer

Bertrand Cariou, Samy Hadjadj, Matthieu Wargny, Matthieu Pichelin, Abdallah Al-Salameh, et al.. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia, 2020, 63 (8), pp.1500-1515. ⟨10.1007/s00125-020-05180-x⟩. ⟨hal-02667655v2⟩
772 Consultations
133 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More